Page last updated: 2024-08-23

brimonidine tartrate and Chemotherapy-Induced Acral Erythema

brimonidine tartrate has been researched along with Chemotherapy-Induced Acral Erythema in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duschner, N; Gerber, PA; Homey, B; Weber, GC	1

Trials

1 trial(s) available for brimonidine tartrate and Chemotherapy-Induced Acral Erythema

Article	Year
Brimonidine tartrate 0.33 % gel for the prevention and management of hand-foot syndrome. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2019, Volume: 17, Issue:5 Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Brimonidine Tartrate; Dermatologic Agents; Doxorubicin; Endometrial Neoplasms; Female; Hand-Foot Syndrome; Humans; Middle Aged	2019

Article

Year

Brimonidine tartrate 0.33 % gel for the prevention and management of hand-foot syndrome.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2019, Volume: 17, Issue:5

Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Brimonidine Tartrate; Dermatologic Agents; Doxorubicin; Endometrial Neoplasms; Female; Hand-Foot Syndrome; Humans; Middle Aged

2019